BeOne Medicines Ag
(NASDAQ) ONC
BeOne Medicines Ag Financials at a Glance
Market Cap
$27.00B
Revenue (TTM)
$5.74B
Net Income (TTM)
$513.02M
EPS (TTM)
$4.48
P/E Ratio
58.89
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$263.39
Volume
299,595
Open
$268.20
Price
$263.39
Volume
299,595
Open
$268.20
Previous Close
$263.92
Daily Range
$262.87 - $268.88
52-Week Range
$239.25 - $385.22
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$263.39
Volume
299,595
Open
$268.20
Previous Close
$263.92
Daily Range
$262.87 - $268.88
52-Week Range
$239.25 - $385.22
Estimated Earnings Date
Aug 5, 2026
ONC News
Why Shares of BeiGene Popped Today
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BeOne Medicines Ag
Industry
Biotechnology
Sector
Health CareEmployees
12,000
CEO
John V. Oyler, MBA
Website
beonemedicines.comHeadquarters
US
ONC Financials
Key Financial Metrics (TTM)
Gross Margin
87%
Operating Margin
12%
Net Income Margin
9%
Return on Equity
12%
Return on Capital
10%
Return on Assets
6%
Earnings Yield
1.70%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$27.00B
Shares Outstanding
102.30M
Volume
299.60K
Avg. Volume
238.23K
Financials (TTM)
Gross Profit
$4.67B
Operating Income
$447.14M
EBITDA
$616.77M
Operating Cash Flow
$1.13B
Capital Expenditure
-$185.84M
Free Cash Flow
$941.74M
Cash & ST Invst.
$4.55B
Total Debt
$2.00B
BeOne Medicines Ag Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.51B
+35.5%
Gross Profit
$1.35B
+41.4%
Gross Margin
88.95%
N/A
Market Cap
$27.00B
N/A
Market Cap/Employee
$2.45M
N/A
Employees
11,000
N/A
Net Income
$227.36M
+17802.1%
EBITDA
$333.25M
+449.0%
Quarterly Fundamentals
Total Cash
$4.79B
+90.4%
Total Debt
$1.15B
+15.3%
Accounts Receivable
$948.36M
+27.1%
Inventory
$681.59M
+37.8%
Long Term Debt
$1.01B
+370.7%
Short Term Debt
$136.72M
-82.5%
Return on Assets
6.00%
N/A
Return on Invested Capital
10.20%
N/A
Free Cash Flow
$161.03M
+322.6%
Operating Cash Flow
$201.94M
+358.1%